Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Employment agrmnt
Quarterly results
Director departure
Appointed director
|
|
Provention Bio, Inc. (PRVB)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 04/28/2023 |
4
| Sessa Capital (Master), L.P. (10% Owner) has filed a Form 4 on Provention Bio, Inc.|
Txns:
| Unknown transaction of 15,567,497 shares
@ $0 |
|
| 04/27/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/27/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/27/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/27/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/27/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/27/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/27/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/27/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/27/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/27/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/27/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/27/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/27/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/27/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/24/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/18/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/14/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/14/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/04/2023 |
4
| Sessa Capital (Master), L.P. (10% Owner) has filed a Form 4 on Provention Bio, Inc.|
Txns:
| Disposed of 3,000,000 shares
@ $0
Gifted 218,651 shares
@ $0 |
|
| 02/14/2023 |
4
| Leon Francisco (Chief Scientific Officer) has filed a Form 4 on Provention Bio, Inc.|
Txns:
| Sold 50,000 shares
@ $10.1121, valued at
$505.6k
Sold 25,985 shares
@ $10.0421, valued at
$260.9k
Exercised 50,000 options to buy
@ $2.5, valued at
$125k
Exercised 25,985 options to buy
@ $2.5, valued at
$65k
|
|
| 02/14/2023 |
4
| Hoitt Jason (Chief Commercial Officer) has filed a Form 4 on Provention Bio, Inc.|
Txns:
| Sold 4,500 shares
@ $10.0012, valued at
$45k
|
|
| 02/14/2023 |
4
| Palmer Ashleigh (Director and CEO) has filed a Form 4 on Provention Bio, Inc.|
Txns:
| Sold 50,000 shares
@ $10.1111, valued at
$505.6k
Sold 25,835 shares
@ $10.0425, valued at
$259.4k
Exercised 50,000 options to buy
@ $2.5, valued at
$125k
Exercised 25,835 options to buy
@ $2.5, valued at
$64.6k
|
|
| 01/20/2023 |
4
| Palmer Ashleigh (Director and CEO) has filed a Form 4 on Provention Bio, Inc.|
Txns:
| Sold 24,165 shares
@ $10.2654, valued at
$248.1k
Exercised 24,165 options to buy
@ $2.5, valued at
$60.4k
|
|
| 01/20/2023 |
4
| Leon Francisco (Chief Scientific Officer) has filed a Form 4 on Provention Bio, Inc.|
Txns:
| Sold 24,015 shares
@ $10.2679, valued at
$246.6k
Exercised 24,015 options to buy
@ $2.5, valued at
$60k
|
|
| 01/20/2023 |
4
| Sessa Capital (Master), L.P. (10% Owner) has filed a Form 4 on Provention Bio, Inc.|
Txns:
| Sold 3,000,000 shares
@ $9.4, valued at
$28.2M
|
|
| 01/18/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/11/2023 |
4
| Vogel Justin (Chief Accounting Officer) has filed a Form 4 on Provention Bio, Inc.|
Txns:
| Granted 84,000 options to buy
@ $8.93, valued at
$750.1k
|
|
| 01/11/2023 |
4
| Ramos Eleanor (Chief Medical Officer) has filed a Form 4 on Provention Bio, Inc.|
Txns:
| Granted 210,000 options to buy
@ $8.93, valued at
$1.9M
|
|
| 01/11/2023 |
4
| Yi Miyoko Christina (Chief Operations Officer) has filed a Form 4 on Provention Bio, Inc.|
Txns:
| Granted 21,000 options to buy
@ $5.88, valued at
$123.5k
Granted 187,000 options to buy
@ $8.93, valued at
$1.7M
|
|
| 01/11/2023 |
4
| Osorio Benedict (Chief Quality Officer) has filed a Form 4 on Provention Bio, Inc.|
Txns:
| Granted 187,000 options to buy
@ $8.93, valued at
$1.7M
|
|
| 01/11/2023 |
4
| O'Brien Sarah (Chief People Officer) has filed a Form 4 on Provention Bio, Inc.|
Txns:
| Granted 8,000 options to buy
@ $5.35, valued at
$42.8k
Granted 100,000 options to buy
@ $8.93, valued at
$893k
|
|
| 01/11/2023 |
4
| Leon Francisco (Chief Scientific Officer) has filed a Form 4 on Provention Bio, Inc.|
Txns:
| Granted 210,000 options to buy
@ $8.93, valued at
$1.9M
|
|
| 01/11/2023 |
4
| King-Jones Heidy (Chief Legal Officer) has filed a Form 4 on Provention Bio, Inc.|
Txns:
| Granted 200,000 options to buy
@ $8.93, valued at
$1.8M
|
|
|
|
|